Eric Joseph
Stock Analyst at JP Morgan
(2.00)
# 2,792
Out of 4,784 analysts
130
Total ratings
39.02%
Success rate
-9.16%
Average return
Main Sectors:
Stocks Rated by Eric Joseph
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PTCT PTC Therapeutics | Maintains: Overweight | $72 → $78 | $48.51 | +60.79% | 8 | Mar 14, 2025 | |
| BLUE bluebird bio | Upgrades: Neutral | n/a | $5.13 | - | 3 | Feb 24, 2025 | |
| PLRX Pliant Therapeutics | Downgrades: Neutral | n/a | $1.41 | - | 4 | Feb 10, 2025 | |
| NRIX Nurix Therapeutics | Maintains: Overweight | $31 → $30 | $11.85 | +153.27% | 7 | Jan 29, 2025 | |
| IGMS IGM Biosciences | Upgrades: Neutral | n/a | $1.18 | - | 8 | Jan 13, 2025 | |
| VIR Vir Biotechnology | Maintains: Neutral | $10 → $14 | $6.42 | +118.07% | 5 | Jan 9, 2025 | |
| RVMD Revolution Medicines | Maintains: Overweight | $63 → $71 | $35.12 | +102.16% | 6 | Dec 3, 2024 | |
| TGTX TG Therapeutics | Maintains: Overweight | $30 → $43 | $38.43 | +11.89% | 4 | Nov 25, 2024 | |
| SEPN Septerna | Initiates: Overweight | $38 | $5.63 | +574.96% | 1 | Nov 19, 2024 | |
| CAMP Camp4 Therapeutics | Initiates: Overweight | $23 | $3.99 | +476.44% | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $17 | $8.17 | +108.21% | 2 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $23 → $21 | $2.58 | +715.53% | 5 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $8 → $9 | $6.58 | +36.88% | 7 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $45 → $48 | $19.46 | +146.66% | 3 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $11 → $10 | $5.42 | +84.50% | 4 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $50 → $54 | $6.69 | +707.78% | 2 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.49 | - | 4 | Jul 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $16 → $15 | $1.88 | +700.00% | 4 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $15 | $2.20 | +581.82% | 1 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $34 → $47 | $28.26 | +66.31% | 2 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $6 | $1.69 | +256.08% | 4 | Jan 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $11 → $10 | $5.29 | +89.21% | 2 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $31 → $11 | $4.76 | +131.34% | 2 | Oct 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $62 → $41 | $40.23 | +1.93% | 2 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $5 | $0.53 | +847.87% | 1 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $28 → $5 | $0.48 | +941.67% | 2 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $2.96 | - | 6 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $11 | $2.86 | +284.62% | 6 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $10.90 | - | 2 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $120 | $4.12 | +2,812.62% | 2 | Feb 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $750 → $300 | $8.41 | +3,469.30% | 2 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $8.36 | - | 2 | Oct 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $50 | $4.84 | +933.06% | 1 | Jul 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $24 → $9 | $1.59 | +467.82% | 2 | Jan 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $1.94 | - | 4 | Jan 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $42 | $1.55 | +2,618.45% | 1 | Feb 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $11 → $13 | $1.42 | +818.73% | 2 | Jan 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $35 → $11 | $0.74 | +1,386.89% | 3 | Nov 14, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $1.67 | - | 3 | Mar 2, 2018 |
PTC Therapeutics
Mar 14, 2025
Maintains: Overweight
Price Target: $72 → $78
Current: $48.51
Upside: +60.79%
bluebird bio
Feb 24, 2025
Upgrades: Neutral
Price Target: n/a
Current: $5.13
Upside: -
Pliant Therapeutics
Feb 10, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.41
Upside: -
Nurix Therapeutics
Jan 29, 2025
Maintains: Overweight
Price Target: $31 → $30
Current: $11.85
Upside: +153.27%
IGM Biosciences
Jan 13, 2025
Upgrades: Neutral
Price Target: n/a
Current: $1.18
Upside: -
Vir Biotechnology
Jan 9, 2025
Maintains: Neutral
Price Target: $10 → $14
Current: $6.42
Upside: +118.07%
Revolution Medicines
Dec 3, 2024
Maintains: Overweight
Price Target: $63 → $71
Current: $35.12
Upside: +102.16%
TG Therapeutics
Nov 25, 2024
Maintains: Overweight
Price Target: $30 → $43
Current: $38.43
Upside: +11.89%
Septerna
Nov 19, 2024
Initiates: Overweight
Price Target: $38
Current: $5.63
Upside: +574.96%
Camp4 Therapeutics
Nov 5, 2024
Initiates: Overweight
Price Target: $23
Current: $3.99
Upside: +476.44%
Oct 17, 2024
Maintains: Overweight
Price Target: $13 → $17
Current: $8.17
Upside: +108.21%
Sep 10, 2024
Maintains: Overweight
Price Target: $23 → $21
Current: $2.58
Upside: +715.53%
Aug 12, 2024
Maintains: Underweight
Price Target: $8 → $9
Current: $6.58
Upside: +36.88%
Aug 7, 2024
Maintains: Overweight
Price Target: $45 → $48
Current: $19.46
Upside: +146.66%
Aug 6, 2024
Maintains: Underweight
Price Target: $11 → $10
Current: $5.42
Upside: +84.50%
Aug 6, 2024
Maintains: Overweight
Price Target: $50 → $54
Current: $6.69
Upside: +707.78%
Jul 8, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.49
Upside: -
May 13, 2024
Maintains: Overweight
Price Target: $16 → $15
Current: $1.88
Upside: +700.00%
May 3, 2024
Maintains: Neutral
Price Target: $14 → $15
Current: $2.20
Upside: +581.82%
Feb 23, 2024
Maintains: Overweight
Price Target: $34 → $47
Current: $28.26
Upside: +66.31%
Jan 29, 2024
Upgrades: Neutral
Price Target: $6
Current: $1.69
Upside: +256.08%
Nov 13, 2023
Maintains: Neutral
Price Target: $11 → $10
Current: $5.29
Upside: +89.21%
Oct 19, 2023
Maintains: Overweight
Price Target: $31 → $11
Current: $4.76
Upside: +131.34%
Oct 11, 2023
Maintains: Overweight
Price Target: $62 → $41
Current: $40.23
Upside: +1.93%
Aug 28, 2023
Downgrades: Neutral
Price Target: $15 → $5
Current: $0.53
Upside: +847.87%
Aug 28, 2023
Downgrades: Neutral
Price Target: $28 → $5
Current: $0.48
Upside: +941.67%
Aug 10, 2023
Downgrades: Underweight
Price Target: n/a
Current: $2.96
Upside: -
Aug 9, 2023
Maintains: Neutral
Price Target: $10 → $11
Current: $2.86
Upside: +284.62%
Nov 29, 2022
Downgrades: Underweight
Price Target: n/a
Current: $10.90
Upside: -
Feb 9, 2022
Upgrades: Neutral
Price Target: $120
Current: $4.12
Upside: +2,812.62%
Jan 7, 2022
Downgrades: Neutral
Price Target: $750 → $300
Current: $8.41
Upside: +3,469.30%
Oct 8, 2021
Downgrades: Underweight
Price Target: n/a
Current: $8.36
Upside: -
Jul 12, 2021
Initiates: Neutral
Price Target: $50
Current: $4.84
Upside: +933.06%
Jan 29, 2021
Downgrades: Neutral
Price Target: $24 → $9
Current: $1.59
Upside: +467.82%
Jan 29, 2021
Downgrades: Underweight
Price Target: n/a
Current: $1.94
Upside: -
Feb 24, 2020
Initiates: Overweight
Price Target: $42
Current: $1.55
Upside: +2,618.45%
Jan 24, 2019
Upgrades: Neutral
Price Target: $11 → $13
Current: $1.42
Upside: +818.73%
Nov 14, 2018
Maintains: Neutral
Price Target: $35 → $11
Current: $0.74
Upside: +1,386.89%
Mar 2, 2018
Downgrades: Underweight
Price Target: n/a
Current: $1.67
Upside: -